1. Home
  2. PLSE vs IRS Comparison

PLSE vs IRS Comparison

Compare PLSE & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • IRS
  • Stock Information
  • Founded
  • PLSE 2014
  • IRS 1943
  • Country
  • PLSE United States
  • IRS Argentina
  • Employees
  • PLSE N/A
  • IRS N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • IRS Homebuilding
  • Sector
  • PLSE Health Care
  • IRS Real Estate
  • Exchange
  • PLSE Nasdaq
  • IRS Nasdaq
  • Market Cap
  • PLSE 1.2B
  • IRS 1.1B
  • IPO Year
  • PLSE 2016
  • IRS 1994
  • Fundamental
  • Price
  • PLSE $19.74
  • IRS $15.05
  • Analyst Decision
  • PLSE
  • IRS Strong Buy
  • Analyst Count
  • PLSE 0
  • IRS 1
  • Target Price
  • PLSE N/A
  • IRS $12.62
  • AVG Volume (30 Days)
  • PLSE 133.6K
  • IRS 201.4K
  • Earning Date
  • PLSE 10-30-2024
  • IRS 02-11-2025
  • Dividend Yield
  • PLSE N/A
  • IRS 11.08%
  • EPS Growth
  • PLSE N/A
  • IRS N/A
  • EPS
  • PLSE N/A
  • IRS N/A
  • Revenue
  • PLSE N/A
  • IRS $370,002,935.00
  • Revenue This Year
  • PLSE N/A
  • IRS N/A
  • Revenue Next Year
  • PLSE N/A
  • IRS N/A
  • P/E Ratio
  • PLSE N/A
  • IRS N/A
  • Revenue Growth
  • PLSE N/A
  • IRS N/A
  • 52 Week Low
  • PLSE $6.60
  • IRS $7.32
  • 52 Week High
  • PLSE $22.69
  • IRS $17.67
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 58.11
  • IRS 46.61
  • Support Level
  • PLSE $17.35
  • IRS $14.30
  • Resistance Level
  • PLSE $19.90
  • IRS $16.05
  • Average True Range (ATR)
  • PLSE 1.05
  • IRS 0.82
  • MACD
  • PLSE 0.15
  • IRS -0.03
  • Stochastic Oscillator
  • PLSE 80.47
  • IRS 42.86

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)

IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segment includes Shopping Malls; Offices; Sales and Developments; Hotels and others. It generates maximum revenue from the Shopping Malls segment. The Shopping Malls segment comprised of lease and service revenues related to rental of commercial space and other spaces in the shopping malls of the company.

Share on Social Networks: